🟢 Connect Biopharma is trading 9.2% up in pre-market with no confirmed catalyst

Connect Biopharma is trading 9.2% up in pre-market at $2.49, with no confirmed catalyst identified.

• It closed at $2.28 on August 20, 2026.
• No new company-specific announcement was identified for August 21, 2026.
• The latest material update remains the August 12 quarterly report, which highlighted completed Phase 2 asthma and COPD enrollment and September topline results; recent biotech volatility may be contributing.